ArticleJournal of experimental & clinical cancer research : CR2022

Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.

Beilei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.